RT Journal Article
SR Electronic
T1 Physical, psychological and cognitive profile of post-COVID condition in healthcare workers, Quebec, Canada
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.08.22272057
DO 10.1101/2022.03.08.22272057
A1 Carazo, Sara
A1 Skowronski, Danuta M.
A1 Laforce, Robert
A1 Talbot, Denis
A1 Falcone, Emilia L.
A1 Laliberté, Denis
A1 Denis, Geoffroy
A1 Deshaies, Pierre
A1 Hegg-Deloye, Sandrine
A1 De Serres, Gaston
YR 2022
UL http://medrxiv.org/content/early/2022/03/09/2022.03.08.22272057.abstract
AB Importance Most adults with COVID-19 do not require hospitalization, but the subsequent risk of post-COVID condition, including associated psychological and cognitive dysfunction, remains poorly understood among non-hospitalized versus hospitalized cases.Objective To assess the prevalence and duration of post-COVID condition, including physical, psychological and cognitive symptoms.Design Case series and case-control study between December 2020 and May 2021Setting Healthcare workers in Quebec, CanadaParticipants Eligible cases were symptomatic healthcare workers with PCR-confirmed COVID-19 between July 2020 and May 2021. Among 17,717 contacted cases, 6061 (34%) participated. A random sample of symptomatic healthcare workers with negative PCR result between November 2020 and May 2021 served as controls. Among 11,498 contacted controls, 4390 (38%) participated.Exposures In multivariable models, sociodemographic and clinical characteristics, as well as vaccine history, were evaluated as potential risk factors. Prevalence ratios compared self-reported cognitive dysfunctions (difficulty concentrating; difficulty organizing oneself; forgetfulness; loss of necessary items) among cases with post-COVID condition to controls, adjusting for psychological distress and fatigue.Outcomes Post-COVID condition was defined by symptoms persisting ≥4 weeks or ≥12 weeks after COVID-19 onset.Results Four-week and 12-week post-COVID condition prevalences of 46% (2,746/5,943) and 40% (653/1,746), respectively, were observed among non-hospitalized cases and 76% (90/118) and 68% (27/37), respectively, among hospitalized cases. Hospitalization, female sex and age were associated with higher risk.A substantial proportion of non-hospitalized cases with 4-week post-COVID condition often or very often reported cognitive dysfunction, including concentration (33%) or organizing (23%) difficulties, forgetfulness (20%) and loss of necessary items (10%), with no decline at 12 weeks. All four aspects of cognitive dysfunction were 2.2 to 3.0 times more prevalent among cases with post-COVID condition than in controls, but also independently associated with psychological distress and fatigue.Conclusions and relevance Post-COVID condition may be a frequent sequela of ambulatory COVID-19 in working-age adults, with important effects on cognition. With so many healthcare workers infected since the beginning of the COVID-19 pandemic, the ongoing implications for quality healthcare delivery could be profound should cognitive dysfunction and other severe post-COVID symptoms persist in a professionally-disabling way over the longer term.Question How common and long-lasting are the physical, psychological and cognitive effects of post-COVID condition in healthcare workers, both hospitalized and non-hospitalized?Findings The prevalence of post-COVID condition was 46% at 4 weeks and 40% at 12 weeks among non-hospitalized cases and 76% and 68% among hospitalized cases. One third of non-hospitalized healthcare workers with post-COVID condition reported cognitive impairment, which was independently associated with persistent physical symptoms, but also psychological distress and fatigue.Meaning Persistent cognitive and other professionally-disabling sequelae of COVID-19 in essential workers could have critical implications for quality healthcare delivery during and after the pandemic.Competing Interest StatementAll authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest. GDS received a grant from Pfizer for anti-meningococcal immunogenicity study not related to this study. GD participated as a medical advisor on the provincial Public Health scientific committee on COVID-19 (Ministry of Health and Social Services, Quebec). All other authors report no potential conflicts.Funding StatementThis work was supported by the Ministère de la santé et des services sociaux du QuébecAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the research ethics committee of the Centre hospitalier universitaire de Québec - Université Laval. All participants gave verbal consent during the phone contact and electronic consent at the beginning of the survey.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOnly data contained in the manuscript is available